Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine whether dehydroepiandrosterone (DHEA) administration
improves fatigue and general well-being in patients with systemic lupus erythematosus or
primary Sjögren's syndrome
Phase:
Phase 2
Details
Lead Sponsor:
UMC Utrecht
Collaborators:
Dutch Arthritis Association University Medical Center Groningen